Legend Biotech Corp Financial Liabilities At Amortised Cost
Legend Biotech Corp (LEGN) had Financial Liabilities At Amortised Cost of $499.80 million as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:FinancialLiabilitiesAtAmortisedCost · last filed 2026-03-10
- 2025-12-31: Financial Liabilities At Amortised Cost $499.80M.
- 2024-12-31: Financial Liabilities At Amortised Cost $395.50M; Financial Liabilities At Amortised Cost as first filed $395.45M.
- 2023-12-31: Financial Liabilities At Amortised Cost $362.79M; Financial Liabilities At Amortised Cost as first filed $360.78M.
- 2022-12-31: Financial Liabilities At Amortised Cost $328.39M.
| Period end | Financial Liabilities At Amortised Cost | Financial Liabilities At Amortised Cost as first filed |
|---|---|---|
| 2025-12-31 | $499.80M 20-F · filed 2026-03-10 | |
| 2024-12-31 | $395.50M 20-F · filed 2026-03-10 | $395.45M 20-F · filed 2025-03-11 |
| 2023-12-31 | $362.79M 20-F · filed 2025-03-11 | $360.78M 20-F · filed 2024-03-19 |
| 2022-12-31 | $328.39M 20-F · filed 2024-03-19 | |
| 2021-12-31 | $146.88M 20-F · filed 2023-03-30 | |
| 2021-06-30 | $55.87M 6-K · filed 2021-08-23 | |
| 2020-12-31 | $34.37M 20-F/A · filed 2023-02-17 | $94.17M 20-F · filed 2021-04-02 |
| 2019-12-31 | $79.89M 20-F · filed 2021-04-02 |